Cargando…

miR-622 Counteracts the NUAK1-Induced Gastric Cancer Cell Proliferation and the Antioxidative Stress

BACKGROUND: Gastric cancer (GC), a highly prevalent gastric cancer, has high-risk mortality. Thus, investigating strategies to counteract its growth is important to provide theoretical guidance for its prevention and treatment. It has been pointed out that abnormal expression of microRNAs (miRNAs) s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jian, Lu, Jian, Yin, Ni, Sun, Jingyue, Pu, Jianhong, Zang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303142/ https://www.ncbi.nlm.nih.gov/pubmed/35872695 http://dx.doi.org/10.1155/2022/9616764

Ejemplares similares

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
por: Orlandella, Francesca Maria, et al.
Publicado: (2020)

Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer
por: Liu, Chuanyang, et al.
Publicado: (2019)

MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1
por: Shi, L, et al.
Publicado: (2014)

Circ_0005918 Sponges miR-622 to Aggravate Intervertebral Disc Degeneration
por: Cui, Yan, et al.
Publicado: (2022)

Hsa_circ_0101432 promotes the development of hepatocellular carcinoma (HCC) by adsorbing miR-1258 and miR-622
por: Zou, Haibo, et al.
Publicado: (2019)

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
por: Wang, Renjie, et al.
Publicado: (2018)

NUAK1 and NUAK2 Fine-Tune TGF-β Signaling
por: van de Vis, Reinofke A. J., et al.
Publicado: (2021)

EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
por: Liu, Haiou, et al.
Publicado: (2015)

miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Publicado: (2021)

Sevoflurane inhibits malignant progression of colorectal cancer via hsa_circ_0000231-mediated miR-622
por: Wang, Jingpeng, et al.
Publicado: (2021)

Decrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cells
por: Wang, Yong, et al.
Publicado: (2017)

Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
por: Liu, Haiou, et al.
Publicado: (2021)

NUAK Kinases: Brain–Ovary Axis
por: Molina, Ester, et al.
Publicado: (2021)

The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2018)

miR-18a counteracts AKT and ERK activation to inhibit the proliferation of pancreatic progenitor cells
por: Li, Xuyan, et al.
Publicado: (2017)

Silencing of circular RNA ANRIL attenuates oxygen–glucose deprivation and reoxygenation-induced injury in human brain microvascular endothelial cells by sponging miR-622
por: Jiang, Su, et al.
Publicado: (2020)

LncRNA NEAT1/miR-204/NUAK1 Axis is a Potential Therapeutic Target for Non-Small Cell Lung Cancer
por: Zhao, Ming-Ming, et al.
Publicado: (2020)

lncRNA FGD5-AS1 promotes breast cancer progression by regulating the hsa-miR-195-5p/NUAK2 axis
por: Fang, Kun, et al.
Publicado: (2021)

NUAK2: an emerging acral melanoma oncogene
por: Namiki, Takeshi, et al.
Publicado: (2011)

NUAK1 links genomic instability and senescence
por: Bernard, David, et al.
Publicado: (2010)

Calcium signalling links MYC to NUAK1
por: Monteverde, T, et al.
Publicado: (2018)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways
por: Liu, Shuting, et al.
Publicado: (2021)

Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2023)

Ursolic Acid Inhibits the Proliferation of Gastric Cancer Cells by Targeting miR-133a
por: Xiang, Fenfen, et al.
Publicado: (2015)

Reduction of miR-132-3p contributes to gastric cancer proliferation by targeting MUC13
por: He, Liang, et al.
Publicado: (2017)

Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma
por: Zang, Jian, et al.
Publicado: (2018)

Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells
por: Tao, Pengfei, et al.
Publicado: (2019)

miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3
por: Feng, Lan, et al.
Publicado: (2019)

miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9
por: Sun, Qin Hui, et al.
Publicado: (2020)

TFAP2E methylation promotes 5-fluorouracil resistance via exosomal miR-106a-5p and miR-421 in gastric cancer MGC-803 cells
por: Jingyue, Sun, et al.
Publicado: (2019)

¡MS-DOS 6.22 fácil!
por: Fulton, Jennifer
Publicado: (1994)

MCITP 70-622 exam cram
por: Mancuso, Paul, et al.
Publicado: (2008)

Using MS-DOS 6.22
por: Cooper, Jim
Publicado: (2002)

Downregulated miR-383-5p contributes to the proliferation and migration of gastric cancer cells and is associated with poor prognosis
por: Wei, Chao, et al.
Publicado: (2019)

Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018)

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
por: Liu, Yuhan, et al.
Publicado: (2023)

A novel long noncoding RNA SP100-AS1 induces radioresistance of colorectal cancer via sponging miR-622 and stabilizing ATG3
por: Zhou, You, et al.
Publicado: (2022)

miR‐212 as potential biomarker suppresses the proliferation of gastric cancer via targeting SOX4
por: Shao, Jian‐Ping, et al.
Publicado: (2020)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vhq0ic01s3ismir5vqm0a68t0e